Back

Senescence and DNA Damage-Induced Inflammation Drive Heart Failure with Preserved Ejection Fraction in Cardiovascular Kidney Metabolic Syndrome

Dai, D.-F.; Zhu, J.-y.; Gao, M.; Wang, K.; Daneshgar, N.; Yang, X. P.; Hahn, V. S.; Talor, M. V.; Cihakova, D.; Rosenberg, A. Z.; Hinton, A.; Han, Z.

2026-04-16 pathology
10.64898/2026.04.13.718331 bioRxiv
Show abstract

IntroductionHeart failure with preserved ejection fraction (HFpEF) is strongly associated with cardiometabolic comorbidities, including obesity, diabetes, hypertension, chronic kidney disease and aging, yet the mechanistic contribution of cellular senescence to HFpEF pathogenesis remains poorly defined. Methods and ResultsTo model clinically relevant HFpEF, we subjected p16-3MR mice to a novel chronic "four-hit" cardiovascular-kidney-metabolic stress regimen (10 months of a high-fat diet, low-dose streptozotocin, L-NAME, and aging). These mice developed a robust HFpEF phenotype characterized by left ventricular hypertrophy, impaired diastolic function (reduced E'/A' and elevated E/E'), preserved ejection fraction, reduced -dP/dt, exercise intolerance, pulmonary congestion, and increased cardiac CD68 macrophage infiltration. Cardiac proteomics identified 821 proteins significantly altered by four-hit stress. Selective genetic ablation of p16 senescent cells using ganciclovir ameliorated HFpEF phenotypes, reduced cardiac p16 expression and inflammation, and normalized proteomic remodeling, without affecting body weight or glycemic status. Comparative network analysis of mouse and human HFpEF cardiac proteomes revealed highly concordant upstream regulatory networks, prominently involving cell-cycle control, DNA damage responses, and inflammatory signaling. Immunohistochemical analysis of human HFpEF cardiac biopsies confirmed increased p16, {gamma}H2AX, STING, IRF3, NF-{kappa}B p65, and CD68 macrophages, mirroring the murine findings. The 4-Hit mice also developed chronic diabetic kidney disease with increased kidney inflammation, both of which were attenuated by Senolytic therapy. Mechanistically, the cGAS-STING (cyclic GMP-AMP synthase - stimulator of interferon genes) is activated in response to damaged DNA, which in turn activates the downstream immune responses, including NF-{kappa}B and interferons. Cross-species validation further demonstrated that combined metabolic stress impaired cardiac function and nephrocyte function in Drosophila. Cardiac and nephrocyte dysfunctions were independently rescued by cardiomyocyte-specific and nephrocyte-specific inhibition of the cGAS-STING pathway, respectively. In human iPSC-derived cardiomyocytes, irradiation and palmitate induced senescence, DNA damage sensing via ZBP1, and activation of the cGAS-STING-IRF3 signaling axis; ZBP1 knockdown or senolytic treatment suppressed this inflammatory axis. ConclusionsAcross mouse, human, fly, and human iPSC models, our findings identify DNA damage-driven senescence and ZBP1-cGAS-STING signaling as conserved, causal mechanisms linking cardiovascular-kidney-metabolic comorbidities to HFpEF, highlighting senescence and innate immune pathways as promising therapeutic targets.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Aging Cell
144 papers in training set
Top 0.7%
10.1%
2
Nature Communications
4913 papers in training set
Top 22%
8.4%
3
Circulation
66 papers in training set
Top 0.6%
6.4%
4
Journal of Clinical Investigation
164 papers in training set
Top 0.3%
6.3%
5
Cardiovascular Research
33 papers in training set
Top 0.1%
4.9%
6
Journal of the American Society of Nephrology
52 papers in training set
Top 0.2%
4.9%
7
Circulation Research
39 papers in training set
Top 0.2%
4.9%
8
JCI Insight
241 papers in training set
Top 1%
3.7%
9
Circulation: Heart Failure
14 papers in training set
Top 0.1%
3.7%
50% of probability mass above
10
Disease Models & Mechanisms
119 papers in training set
Top 0.9%
1.9%
11
Stem Cell Reports
118 papers in training set
Top 0.4%
1.9%
12
Cell Reports Medicine
140 papers in training set
Top 3%
1.8%
13
Journal of the American Heart Association
119 papers in training set
Top 3%
1.7%
14
Cell Stem Cell
57 papers in training set
Top 1%
1.7%
15
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.7%
16
Cell Reports
1338 papers in training set
Top 24%
1.7%
17
Human Molecular Genetics
130 papers in training set
Top 2%
1.7%
18
eBioMedicine
130 papers in training set
Top 2%
1.3%
19
Cells
232 papers in training set
Top 4%
1.2%
20
Journal of Molecular and Cellular Cardiology
39 papers in training set
Top 0.6%
1.2%
21
Cell Death & Disease
126 papers in training set
Top 1%
1.2%
22
Advanced Science
249 papers in training set
Top 15%
1.1%
23
Science Translational Medicine
111 papers in training set
Top 4%
1.1%
24
iScience
1063 papers in training set
Top 24%
0.9%
25
Diabetologia
36 papers in training set
Top 0.8%
0.9%
26
eLife
5422 papers in training set
Top 55%
0.8%
27
The American Journal of Pathology
31 papers in training set
Top 0.4%
0.8%
28
The EMBO Journal
267 papers in training set
Top 5%
0.7%
29
Molecular Therapy
71 papers in training set
Top 3%
0.7%
30
PLOS ONE
4510 papers in training set
Top 69%
0.7%